Medical Director of Renal Transplantation at The Christ Hospital
Nephrology
Dr. Michael A. Cardi, MD
|
|
Give Review
Michael A. Cardi works in the field of Nephrology. He attended Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care He has 2 awards "Meaningful Use Stage 1 Certification" and "Top MD". Michael Cardi is also published. He has 24 publications published. The lastest publication: "Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.' He accepts all Medicare patients.
Publications
- Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.
- Improvement and stabilization of chronic Kidney disease after gastric bypass.
- A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor Renal transplantation.
- The influence of immunomodulatory diets on transplant success and complications.
- Corticosteroid elimination: the Cincinnati experience.
- Early steroid Withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.
- Proteasome inhibition reduces donor-specific antibody levels.
- African American renal transplant recipients benefit from early corticosteroid Withdrawal under modern immunosuppression.
- Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study.
- Histocompatibility testing predicts Acute rejection risk in early corticosteroid withdrawal regimens.
- Transplantation Without steroids.
- Outcomes of patients With rejection post-polyomavirus nephropathy.
- Multivariate analysis of risk factors for Acute rejection in early corticosteroid cessation regimens under modern immunosuppression.
- Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated With sirolimus therapy.
- African-American renal transplant recipients benefit from early corticosteroid Withdrawal under modern immunosuppression.
- Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in Renal transplantation.
- A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
- Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal Disease and transplant patients: a pilot study.
- Gastric bypass in morbidly obese patients with chronic renal failure and Kidney transplant.
- Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and Chronic steroids.
- Body weight alterations under early corticosteroid withdrawal and Chronic corticosteroid therapy with modern immunosuppression.
- Bortezomib provides effective therapy for antibody- and cell-mediated Acute rejection.
- Early and late Acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.
Schools
Harvard Medical School
Beth Israel Hospital
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- End-Stage Renal Disease Related Services
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Indemnity Plan
- Worker's Compensation WC
- Comprehensive Benefits Plan
- Health Net
- Health Span EPO
- Health Span HMO
- Health Span POS
- Health Span PPO
- Medicare MCR
- Humana EPO
- Humana HMO
- Humana POS
- Humana PPO
- Medicaid Assignment
- Medicare Assignment MCR
- Neighborhood Health Providers
- Tricare
Awards
- Meaningful Use Stage 1 Certification
- Top MD
Education
-
Beth Israel Deaconess Medical Center -
Harvard Medical School
Hospital
-
Christ Hospital
Drug Facts
| NPI NUMBER | 1801839741 | |
| NPPES Provider LastName | CARDI | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 452192906 | |
| NPPES Provider State | OH | |
| Specialty Description | Nephrology | |
| Total Claim Count | 3716.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 72.0 | |
| Percent Opioid Claims | 1.94 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801839741 |
| Last Name Of The Provider | CARDI |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Jane E. Drenkhahn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin Estes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward C. Sha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepika Suri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir Izhar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Savio M. Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuvraj Sharma, MD
This Doctor is OpenDoctor Recommended.
|